Wednesday, January 19, 2022

Serum Institute

Editorial: Focus on raising vaccine output

The daily vaccination rate has fallen to 1.3 million doses despite India not exporting the vaccines now

Telangana way ahead in vaccination: KTR

The Minister spoke about his personal isolation experience to the decision on imposing lockdown, vaccine for children to India seeking help from other countries, among other things

Foreign vaccine purchase tough task

States may face delays in getting approvals from Indian drug regulatory authorities

Forensic team visits Serum Institute in Pune to probe fire incident

The SII has announced a compensation of Rs 25 lakhs each to the families of deceased.

5 killed in Serum Institute plant fire, Covid vaccine safe

Health Minister Rajesh Tope and Pune Mayor Murlidhar Mohol announced that five persons, including one woman, had perished in the blaze and their bodies were found during the cooling operations.

Major fire breaks out in Serum Institute plant in Pune

At least 10 fire-tenders from Pune Fire Brigade rushed to the site and were battling the blaze, the cause of which is not clear.

Siddipet ZP chief hails Serum Institute, Bharat Biotech

Zilla Parishad Chairperson Roja Sharma was speaking after launching the vaccination drive at Area Hospital, Siddipet on Saturday

Telangana braces for adverse effects of Covid vaccines

58 healthcare centres ready to provide emergency services to individuals with Adverse Events Following Immunisation across State

Telangana gets first batch of Covishield shots

3.64 lakh vials reach storage facility in Koti; all set for roll out on Jan 16

Britain starts virus jabs as Biden vows 100 million vaccinations

The Pfizer-BioNTech jab is one of several vaccines bringing hope for an end to the pandemic that has killed more than 1.5 million people worldwide and ravaged economies.

Serum Institute threatens to sue vaccine volunteer

The SII has rejected charges of side effects claimed by a vaccine trial participant who also sought damages of Rs 5 crore

Serum Institute of India CEO expresses delight at Covishield vaccine efficacy

The Oxford-AstraZeneca vaccine is being made in partnership with Serum Institute.

Serum Institute, ICMR complete enrolment in phase-III trials for COVID-19 vaccine

SII and ICMR are conducting phase II/III clinical trial of the vaccine at 15 different centres across the country.

Latest News

- Advertisement -